President Donald Trump unveiled a deal this month with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy.

Listen now and subscribe: Apple Podcasts | Google Podcasts | Spotify | Stitcher | RSS Feed | SoundStack | All Of Our Podcasts

Columnists

Why did we build communities that discourage walking? | The Ethical Life podcast

Scott Rada

Science

Obesity remains high in the US, but more states show progress, a new report finds

JONEL ALECCIA Associated Press

Health

As world gets hotter, Americans are turning to more sugar, study finds

SETH BORENSTEIN Associated Press

See Full Page